Mamluk Roni
President & CEO at Ayala Pharmaceuticals, Inc.; Director at CHIASMA, INC
- Sold, on record
- $2.3M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Feb 24, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Ayala Pharmaceuticals, Inc.President & CEO
- CHIASMA, INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CHIASMA, INC270,862 shares
- Ayala Pharmaceuticals, Inc.53,998 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CHIASMA, INCUnusualJul 16, 2019 2019
Sold 10,000 shares at $6.35 ($64k)
Mamluk Roni, Director
Sold 100% of holdings ($64k position)0 shares left4.2x usual sizeFiling
- 2 Form 4 sale CHIASMA, INCUnusualSep 20, 2019 +66 days
Sold 50,000 shares at $5.59 ($280k)
Mamluk Roni, Director
Sold 100% of holdings ($280k position)0 shares left13.5x usual sizeFiling
- 3 Form 4 sale CHIASMA, INCUnusualOct 16, 2019 +26 days
Sold 10,000 shares at $4.94 ($49k)
Mamluk Roni, Director
Sold 100% of holdings ($49k position)0 shares left2x usual sizeFiling
- 4 Form 4 sale CHIASMA, INCUnusualDec 20, 2019 +65 days
Sold 61,139 shares at $5.51 ($337k)
Mamluk Roni, Director
Sold 100% of holdings ($337k position)0 shares left8.2x usual sizeFiling
- 5 Form 4 sale CHIASMA, INCUnusualFeb 20, 2020 +62 days
Sold 82,186 shares at $4.54 ($373k)
Mamluk Roni, Director
Sold 100% of holdings ($373k position)0 shares left8.2x usual sizeFiling
- 6 Form 4 sale Ayala Pharmaceuticals, Inc.Plan not statedJan 21, 2021 +336 days
Sold 20,872 shares at $15.03 ($314k)
Mamluk Roni, President & CEO
Sold 10.5% of holdings ($3M position)178,471 shares leftFirst sale on recordFiling
- 7 Form 4 sale CHIASMA, INCUnusualFeb 9, 2021 +19 days
Sold 27,981 shares at $5.00 ($140k)
Mamluk Roni, Director
Sold 100% of holdings ($140k position)0 shares left2.8x usual sizeFiling
- 8 Form 4 sale Ayala Pharmaceuticals, Inc.Plan not statedFeb 24, 2021 +15 days
Sold 33,126 shares at $18.63 ($617k)
Mamluk Roni, President & CEO
Sold 18.6% of holdings ($3.3M position)145,345 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2021 | Feb 24, 2021 | Ayala Pharmaceuticals, Inc. | President & CEO | Form 4 sale | 33,126 | $617k | 18.6% | Plan not stated | SEC |
| Feb 9, 2021 | Feb 11, 2021 | CHIASMA, INC | Director | Form 4 sale | 27,981 | $140k | 100.0% | Unusual | SEC |
| Jan 21, 2021 | Jan 22, 2021 | Ayala Pharmaceuticals, Inc. | President & CEO | Form 4 sale | 20,872 | $314k | 10.5% | Plan not stated | SEC |
| Feb 20, 2020 | Feb 21, 2020 | CHIASMA, INC | Director | Form 4 sale | 82,186 | $373k | 100.0% | Unusual | SEC |
| Dec 20, 2019 | Dec 23, 2019 | CHIASMA, INC | Director | Form 4 sale | 61,139 | $337k | 100.0% | Unusual | SEC |
| Oct 16, 2019 | Oct 17, 2019 | CHIASMA, INC | Director | Form 4 sale | 10,000 | $49k | 100.0% | Unusual | SEC |
| Sep 20, 2019 | Sep 23, 2019 | CHIASMA, INC | Director | Form 4 sale | 50,000 | $280k | 100.0% | Unusual | SEC |
| Jul 16, 2019 | Jul 17, 2019 | CHIASMA, INC | Director | Form 4 sale | 10,000 | $64k | 100.0% | Unusual | SEC |
| Apr 16, 2019 | Apr 17, 2019 | CHIASMA, INC | Director | Form 4 sale | 10,000 | $53k | 100.0% | Unusual | SEC |
| Mar 5, 2019 | Mar 6, 2019 | CHIASMA, INC | Director | Form 4 sale | 5,000 | $25k | 100.0% | Unusual | SEC |
| Jan 22, 2019 | Jan 23, 2019 | CHIASMA, INC | Director | Form 4 sale | 5,000 | $18k | 100.0% | Unusual | SEC |
| Jun 18, 2018 | Jun 20, 2018 | CHIASMA, INC | Director | Form 4 sale | 2,389 | $3k | 100.0% | Unusual | SEC |
| Mar 19, 2018 | Mar 20, 2018 | CHIASMA, INC | Director | Form 4 sale | 2,389 | $4k | 100.0% | Unusual | SEC |
| Dec 18, 2017 | Dec 19, 2017 | CHIASMA, INC | Director | Form 4 sale | 2,389 | $4k | 100.0% | Unusual | SEC |
| Oct 24, 2017 | Oct 26, 2017 | CHIASMA, INC | Director | Form 4 sale | 2,389 | $5k | 100.0% | Unusual | SEC |